Sunrest Lifescience
Sunrest Lifescience (SUNREST) share price was ₹33.50 at the 23 Oct 2026 close; market capitalisation ₹57.50 Cr; sector Healthcare. The share price fell 15.6% over the year to 23 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was ₹36.82 Cr and net profit was ₹6.57 Cr. Promoters held 53.50% of Sunrest Lifescience in Sep 2026, unchanged from Jun 2026.
Key Fundamentals
SMEPharmaceuticals & BiotechnologyHealthcarePrice-based figures as of 23 Oct 2026, 15:30 IST · TTM
Peer Comparison
Healthcare › Pharmaceuticals
| ₹1,765.90 | 35.03 | 4,23,699 Cr | 5.07 | 0.91% | 13.79% | 17.94% | 61,848 Cr | 12,117 Cr | |
| ₹9,652.00 | 87.60 | 2,56,230 Cr | 15.29 | 0.32% | 15.32% | 18.96% | 11,682 Cr | 2,925 Cr | |
| ₹4,596.50 | 72.16 | 1,74,836 Cr | 9.52 | 0.82% | 12.16% | 9.06% | 17,058 Cr | 2,156 Cr | |
| ₹2,190.00 | 108.20 | 1,18,328 Cr | 22.33 | 0.09% | 16.38% | 19.67% | 7,323 Cr | 1,090 Cr | |
| ₹1,181.40 | 26.29 | 1,17,845 Cr | 4.35 | 0.09% | 16.99% | 19.24% | 28,515 Cr | 4,593 Cr | |
| ₹1,337.40 | 34.64 | 1,11,630 Cr | 2.88 | 0.61% | 10.87% | 13.94% | 34,247 Cr | 3,184 Cr | |
| ₹1,363.10 | 32.66 | 1,10,119 Cr | 3.11 | 0.96% | 11.21% | 14.88% | 28,589 Cr | 3,356 Cr | |
| Sunrest Lifescience (this company) | ₹33.50 | — | 58 Cr | 0.70 | 0.00% | 26.99% | 27.46% | 19 Cr | 2 Cr |
| Median 8 companies | ₹1,564.50 | 35.03 | 1,18,087 Cr | 4.71 | 0.47% | 14.56% | 18.45% | 22,787 Cr | 3,055 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
2- Stock is trading at 0.73 times its book value
- Debtor days have improved from 283 to 168 days.
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 168 days.
Technical Indicators
Oscillators
Bearish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 18.33% · Mar 2026
Quarterly Results
| Particulars | Sep 2024 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 15.39 | 34.01 | 36.82 |
| Expenses | 14.48 | 31.56 | 30.07 |
| Operating Profit | 0.91 | 2.45 | 6.75 |
| OPM % | 5.91% | 7.2% | 18.33% |
| Other Income | 0 | 0 | 2.51 |
| Interest | 0.12 | 0.72 | 0.7 |
| Depreciation | 0.01 | 0.68 | 0.51 |
| PBT | 0.78 | 1.05 | 8.05 |
| Tax % | 24.36% | 37.14% | 18.51% |
| Net Profit | 0.58 | 0.66 | 6.57 |
| EPS (₹) | 1.35 | 0.79 | 7.88 |
Profit & Loss
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 33.41 | 70.63 |
| Expenses | 30.38 | 60.42 |
| Operating Profit | 3.03 | 10.21 |
| OPM % | 9.07% | 14.46% |
| Other Income | 0 | 2.51 |
| Interest | 0.31 | 1.42 |
| Depreciation | 0.1 | 1.19 |
| PBT | 2.62 | 10.11 |
| Tax % | 23.28% | 20.87% |
| Net Profit | 2.02 | 8 |
| EPS (₹) | 4.68 | 9.6 |
| Div. Payout % | 0% | 0% |
Balance Sheet
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity Capital | 4.29 | 4.29 |
| Reserves | 12.02 | 16.14 |
| Borrowings | 12.06 | 17.46 |
| Other Liabilities | 30.28 | 33.52 |
| Total Liabilities | 58.65 | 71.41 |
| Fixed Assets | 4.36 | 8.55 |
| CWIP | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 54.29 | 62.86 |
| Total Assets | 58.65 | 71.41 |
Cash Flow
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Operating | 2.92 | -0.05 |
| Investing | -1.15 | -2.91 |
| Financing | -0.33 | 3.99 |
| Net Cash Flow | 1.45 | 1.03 |
| Free Cash Flow | 1.76 | -2.76 |
| CFO/EBITDA | 112 | 14 |
Ratios
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Debtor Days | 397 | 168 |
| Inventory Days | 175 | 141 |
| Days Payable | 417 | 173 |
| Cash Conversion Cycle | 155 | 135 |
| Working Capital Days | 228 | 156 |
| ROCE % | — | 23.22% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sunrest Lifescience insights
58 extracted metrics + investor summaries across FY23–FY26.
Documents
Frequently Asked Questions about Sunrest Lifescience
What does Sunrest Lifescience Ltd do?
Where is Sunrest Lifescience Ltd (SUNREST) listed?
Which sector does Sunrest Lifescience Ltd belong to?
What is the market capitalisation of Sunrest Lifescience Ltd?
What is the 52-week high and low of Sunrest Lifescience Ltd?
What is the Return on Equity (ROE) of Sunrest Lifescience Ltd?
Company Information
Incorporated in 2017, Sunrest Lifescience Ltd trades in Health care and Cosmetics products[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SUNREST.md for Sunrest Lifescience Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.